Medicine Nobelists Tower In Citation Standings

The names James Black, Gertrude Elion, and George Hitchings probably didn’t ring any bells for the general public when this year’s Nobel Prize in physiology or medicine was announced. But among the scientific community this trio of pioneering pharmacologists is widely recognized. In fact, for decades now scientists have been paying their own kind of tribute to Black, Elion, and Hitchings by consistently citing their papers—and at levels far above average. Sir James W Black,

Written byDavid Pendlebury
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The names James Black, Gertrude Elion, and George Hitchings probably didn’t ring any bells for the general public when this year’s Nobel Prize in physiology or medicine was announced. But among the scientific community this trio of pioneering pharmacologists is widely recognized. In fact, for decades now scientists have been paying their own kind of tribute to Black, Elion, and Hitchings by consistently citing their papers—and at levels far above average.

Sir James W Black, 64, King’s College Hospital Medical School in London, was singled out by Sweden’s Karolinska Institute for his formulation in the early 1960s of a beta-blocker drug (propranolol) that has become a mainstay in the treatment of high blood pressure and coronary disease. Of Black’s three most cited papers, the second and third (both published in The Lancet, volume II, page 311, 1962 [about 600 citations], and volume I, page 1080, 1964 [about 470 citations]), discuss ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA